Ancient dao-yin exercise may ease chemotherapy side effects in breast cancer patients

NCT ID NCT07262099

Completed Symptom relief Sponsor: Tri-Service General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a traditional Daoist exercise called Shangshou Dao-yin could improve sleep, body constitution, and quality of life in breast cancer patients undergoing chemotherapy. 150 women who had surgery for breast cancer and were starting chemotherapy were assigned to either practice the exercise daily for 20 minutes or receive standard care. The results may show whether this gentle, equipment-free exercise helps reduce sleep problems and enhance well-being during cancer treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Shangshou Dao-yin (a traditional Daoist mind-body exercise with gentle movements and breathing)
What this could lead to: If it works, this could offer a simple, equipment-free way to help breast cancer patients feel better during chemotherapy, with better sleep and quality of life.
What could go wrong: This is a small, completed study where patients chose their group, not a randomized trial, so results may be less reliable. The exercise may not work for everyone, and benefits might be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Tri-Service General Hospital

Taipei, Taipei City, 11490, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.